Cargando…
A Shared Pathogenic Mechanism for Valproic Acid and SHROOM3 Knockout in a Brain Organoid Model of Neural Tube Defects
Neural tube defects (NTDs), including anencephaly and spina bifida, are common major malformations of fetal development resulting from incomplete closure of the neural tube. These conditions lead to either universal death (anencephaly) or severe lifelong complications (spina bifida). Despite hundred...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10340169/ https://www.ncbi.nlm.nih.gov/pubmed/37443734 http://dx.doi.org/10.3390/cells12131697 |
_version_ | 1785072014401208320 |
---|---|
author | Takla, Taylor N. Luo, Jinghui Sudyk, Roksolana Huang, Joy Walker, John Clayton Vora, Neeta L. Sexton, Jonathan Z. Parent, Jack M. Tidball, Andrew M. |
author_facet | Takla, Taylor N. Luo, Jinghui Sudyk, Roksolana Huang, Joy Walker, John Clayton Vora, Neeta L. Sexton, Jonathan Z. Parent, Jack M. Tidball, Andrew M. |
author_sort | Takla, Taylor N. |
collection | PubMed |
description | Neural tube defects (NTDs), including anencephaly and spina bifida, are common major malformations of fetal development resulting from incomplete closure of the neural tube. These conditions lead to either universal death (anencephaly) or severe lifelong complications (spina bifida). Despite hundreds of genetic mouse models of neural tube defect phenotypes, the genetics of human NTDs are poorly understood. Furthermore, pharmaceuticals, such as antiseizure medications, have been found clinically to increase the risk of NTDs when administered during pregnancy. Therefore, a model that recapitulates human neurodevelopment would be of immense benefit to understand the genetics underlying NTDs and identify teratogenic mechanisms. Using our self-organizing single rosette cortical organoid (SOSR-COs) system, we have developed a high-throughput image analysis pipeline for evaluating the SOSR-CO structure for NTD-like phenotypes. Similar to small molecule inhibition of apical constriction, the antiseizure medication valproic acid (VPA), a known cause of NTDs, increases the apical lumen size and apical cell surface area in a dose-responsive manner. GSK3β and HDAC inhibitors caused similar lumen expansion; however, RNA sequencing suggests VPA does not inhibit GSK3β at these concentrations. The knockout of SHROOM3, a well-known NTD-related gene, also caused expansion of the lumen, as well as reduced f-actin polarization. The increased lumen sizes were caused by reduced cell apical constriction, suggesting that impingement of this process is a shared mechanism for VPA treatment and SHROOM3-KO, two well-known causes of NTDs. Our system allows the rapid identification of NTD-like phenotypes for both compounds and genetic variants and should prove useful for understanding specific NTD mechanisms and predicting drug teratogenicity. |
format | Online Article Text |
id | pubmed-10340169 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-103401692023-07-14 A Shared Pathogenic Mechanism for Valproic Acid and SHROOM3 Knockout in a Brain Organoid Model of Neural Tube Defects Takla, Taylor N. Luo, Jinghui Sudyk, Roksolana Huang, Joy Walker, John Clayton Vora, Neeta L. Sexton, Jonathan Z. Parent, Jack M. Tidball, Andrew M. Cells Article Neural tube defects (NTDs), including anencephaly and spina bifida, are common major malformations of fetal development resulting from incomplete closure of the neural tube. These conditions lead to either universal death (anencephaly) or severe lifelong complications (spina bifida). Despite hundreds of genetic mouse models of neural tube defect phenotypes, the genetics of human NTDs are poorly understood. Furthermore, pharmaceuticals, such as antiseizure medications, have been found clinically to increase the risk of NTDs when administered during pregnancy. Therefore, a model that recapitulates human neurodevelopment would be of immense benefit to understand the genetics underlying NTDs and identify teratogenic mechanisms. Using our self-organizing single rosette cortical organoid (SOSR-COs) system, we have developed a high-throughput image analysis pipeline for evaluating the SOSR-CO structure for NTD-like phenotypes. Similar to small molecule inhibition of apical constriction, the antiseizure medication valproic acid (VPA), a known cause of NTDs, increases the apical lumen size and apical cell surface area in a dose-responsive manner. GSK3β and HDAC inhibitors caused similar lumen expansion; however, RNA sequencing suggests VPA does not inhibit GSK3β at these concentrations. The knockout of SHROOM3, a well-known NTD-related gene, also caused expansion of the lumen, as well as reduced f-actin polarization. The increased lumen sizes were caused by reduced cell apical constriction, suggesting that impingement of this process is a shared mechanism for VPA treatment and SHROOM3-KO, two well-known causes of NTDs. Our system allows the rapid identification of NTD-like phenotypes for both compounds and genetic variants and should prove useful for understanding specific NTD mechanisms and predicting drug teratogenicity. MDPI 2023-06-23 /pmc/articles/PMC10340169/ /pubmed/37443734 http://dx.doi.org/10.3390/cells12131697 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Takla, Taylor N. Luo, Jinghui Sudyk, Roksolana Huang, Joy Walker, John Clayton Vora, Neeta L. Sexton, Jonathan Z. Parent, Jack M. Tidball, Andrew M. A Shared Pathogenic Mechanism for Valproic Acid and SHROOM3 Knockout in a Brain Organoid Model of Neural Tube Defects |
title | A Shared Pathogenic Mechanism for Valproic Acid and SHROOM3 Knockout in a Brain Organoid Model of Neural Tube Defects |
title_full | A Shared Pathogenic Mechanism for Valproic Acid and SHROOM3 Knockout in a Brain Organoid Model of Neural Tube Defects |
title_fullStr | A Shared Pathogenic Mechanism for Valproic Acid and SHROOM3 Knockout in a Brain Organoid Model of Neural Tube Defects |
title_full_unstemmed | A Shared Pathogenic Mechanism for Valproic Acid and SHROOM3 Knockout in a Brain Organoid Model of Neural Tube Defects |
title_short | A Shared Pathogenic Mechanism for Valproic Acid and SHROOM3 Knockout in a Brain Organoid Model of Neural Tube Defects |
title_sort | shared pathogenic mechanism for valproic acid and shroom3 knockout in a brain organoid model of neural tube defects |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10340169/ https://www.ncbi.nlm.nih.gov/pubmed/37443734 http://dx.doi.org/10.3390/cells12131697 |
work_keys_str_mv | AT taklataylorn asharedpathogenicmechanismforvalproicacidandshroom3knockoutinabrainorganoidmodelofneuraltubedefects AT luojinghui asharedpathogenicmechanismforvalproicacidandshroom3knockoutinabrainorganoidmodelofneuraltubedefects AT sudykroksolana asharedpathogenicmechanismforvalproicacidandshroom3knockoutinabrainorganoidmodelofneuraltubedefects AT huangjoy asharedpathogenicmechanismforvalproicacidandshroom3knockoutinabrainorganoidmodelofneuraltubedefects AT walkerjohnclayton asharedpathogenicmechanismforvalproicacidandshroom3knockoutinabrainorganoidmodelofneuraltubedefects AT voraneetal asharedpathogenicmechanismforvalproicacidandshroom3knockoutinabrainorganoidmodelofneuraltubedefects AT sextonjonathanz asharedpathogenicmechanismforvalproicacidandshroom3knockoutinabrainorganoidmodelofneuraltubedefects AT parentjackm asharedpathogenicmechanismforvalproicacidandshroom3knockoutinabrainorganoidmodelofneuraltubedefects AT tidballandrewm asharedpathogenicmechanismforvalproicacidandshroom3knockoutinabrainorganoidmodelofneuraltubedefects AT taklataylorn sharedpathogenicmechanismforvalproicacidandshroom3knockoutinabrainorganoidmodelofneuraltubedefects AT luojinghui sharedpathogenicmechanismforvalproicacidandshroom3knockoutinabrainorganoidmodelofneuraltubedefects AT sudykroksolana sharedpathogenicmechanismforvalproicacidandshroom3knockoutinabrainorganoidmodelofneuraltubedefects AT huangjoy sharedpathogenicmechanismforvalproicacidandshroom3knockoutinabrainorganoidmodelofneuraltubedefects AT walkerjohnclayton sharedpathogenicmechanismforvalproicacidandshroom3knockoutinabrainorganoidmodelofneuraltubedefects AT voraneetal sharedpathogenicmechanismforvalproicacidandshroom3knockoutinabrainorganoidmodelofneuraltubedefects AT sextonjonathanz sharedpathogenicmechanismforvalproicacidandshroom3knockoutinabrainorganoidmodelofneuraltubedefects AT parentjackm sharedpathogenicmechanismforvalproicacidandshroom3knockoutinabrainorganoidmodelofneuraltubedefects AT tidballandrewm sharedpathogenicmechanismforvalproicacidandshroom3knockoutinabrainorganoidmodelofneuraltubedefects |